Tiziana Life Sciences Ltd - Company Profile
Powered by 
All the sales intelligence you need on Tiziana Life Sciences Ltd in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Tiziana Life Sciences Ltd fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Tiziana Life Sciences Ltd.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
The following section provides information on Tiziana Life Sciences Ltd’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Tiziana Life Sciences Ltd's management and employees, unlock the full data with our company analytics monitoring tool.
Executives
Gabriele Marco Antonio Cerrone
Chairman Executive BoardMr. Gabriele Cerrone has been the Chairman of the company since 2022. Mr. Cerrone also co-founded FermaVir Pharmaceuticals Inc. and served as Chairman of the Board until its merger with Inhibitex Inc. in September 2007. Prior to that, he was a Director at Inhibitex Inc.
Ivor Elrifi
Director; Chief Executive Officer Executive BoardMr. Ivor Elrifi has been the Chief Executive Officer and Director of the company since August 2024. Prior to this, Mr. Elrifi served as the global head of the Patent Group at Cooley, a position he held since 2014. Before that, he was the global head of Patents at Mintz Levin from 1999 to 2014.
Keeren Shah
Chief Operating Officer; Chief Financial Officer Senior ManagementMs Keeren Shah serves as the Chief Operating Officer and Chief Financial Officer of the company. She also serves as the Chief Financial Officer at OKYO Pharma Ltd, Accustem Sciences Limited and Rasna Therapeutics Inc. Prior to this, she served as the Senior Leader of Finance at Visa, Inc.
Richard Kim
Chief Medical Officer Senior ManagementMr Richard Kim serves as the Chief Medical Officer of the company. Previously, he served as the medical director at Serono, Inc, global medical affairs director at Biogen Inc, vice president of clinical development at Elan Pharmaceuticals, Inc, vice president of medical affairs at XenoPort, Inc.
William A. Clementi, Ph.D.
Chief Development Officer Senior ManagementDr. William A. Clementi has been the Chief Development Officer of the company since 2023. Prior to this, he served as the Worldwide Director of Market Development at Lorex Pharmaceuticals.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer